Point72 Asset Management
EDIT icon

Point72 Asset Management’s Editas Medicine EDIT Stock Holding History

Point72 Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$406K Buy
125,234
+8,239
+7% +$24.1K ﹤0.01% 3269
2026
Q1 		$289K Sell
116,995
-616,488
-84% -$1.3M ﹤0.01% 3380
2025
Q4 		$1.5M Buy
+733,483
New +$2.12M ﹤0.01% 2651
2024
Q4 		– Sell
-107,360
Closed -$366K – 2159
2024
Q3 		$366K Buy
+107,360
New +$467K ﹤0.01% 1676
2024
Q1 		– Sell
-579,967
Closed -$5.88M – 2294
2023
Q4 		$5.88M Buy
579,967
+577,767
+26,262% +$5.07M 0.01% 866
2023
Q3 		$17.2K Sell
2,200
-879
-29% -$7.54K ﹤0.01% 2301
2023
Q2 		$25.3K Sell
3,079
-224,721
-99% -$1.96M ﹤0.01% 1744
2023
Q1 		$1.65M Buy
+227,800
New +$2.03M 0.01% 1015
2019
Q1 		– Sell
-58,745
Closed -$1.34M – 1071
2018
Q4 		$1.34M Sell
58,745
-38,655
-40% -$1.05M 0.01% 774
2018
Q3 		$3.1M Buy
+97,400
New +$3.15M 0.01% 686

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Point72 Asset Management's EDIT Position: Q2 2026 in Review

Point72 Asset Management increased its Editas Medicine (EDIT) stake by 7% in Q2 2026, buying an estimated $24.1K and bringing the position to 125,234 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #3269.

Point72 Asset Management first reported a position in EDIT in Q3 2018 and has held it in 10 quarters since. The position peaked at $5.88M in Q4 2023. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Point72 Asset Management held 125,234 shares of Editas Medicine worth $406K as of Q2 2026.
  • Point72 Asset Management bought 8,239 Editas Medicine shares in Q2 2026, an estimated $24.1K.
  • Editas Medicine made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #3269 holding.
  • Point72 Asset Management first reported a position in Editas Medicine in Q3 2018 and has held it in 10 quarters since.
  • Point72 Asset Management's Editas Medicine position peaked at $5.88M in Q4 2023.
  • 216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.